For people with pacemakers, how heavy they are (BMI) doesn’t predict death risk — but how much fat they carry around their waist does.
Scientific Claim
In patients with dual-chamber pacemakers, body mass index (BMI) is not significantly associated with all-cause or cardiac mortality, while waist circumference is a stronger predictor of long-term survival.
Original Statement
“All-cause mortality was associated with higher waist circumference (87.6 versus 83.6 cm, P = 0.014), but not body mass index (23.6 versus 23.5, P = 0.930).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study correctly reports non-significant associations (P=0.930) and contrasts WC’s significance, using appropriate correlational language without implying causation.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aWhether the null association between BMI and mortality in pacemaker patients is consistent across studies, and whether WC consistently outperforms BMI.
Whether the null association between BMI and mortality in pacemaker patients is consistent across studies, and whether WC consistently outperforms BMI.
What This Would Prove
Whether the null association between BMI and mortality in pacemaker patients is consistent across studies, and whether WC consistently outperforms BMI.
Ideal Study Design
A meta-analysis of 10+ prospective cohort studies of pacemaker patients (n≥5,000 total) comparing BMI and WC as predictors of all-cause and cardiac mortality, using harmonized adjustment for age, LVEF, and comorbidities.
Limitation: Cannot determine if WC’s superiority is due to measurement precision or biological specificity.
Prospective Cohort StudyLevel 2aWhether WC predicts mortality better than BMI in subgroups (e.g., elderly, diabetic, HFpEF).
Whether WC predicts mortality better than BMI in subgroups (e.g., elderly, diabetic, HFpEF).
What This Would Prove
Whether WC predicts mortality better than BMI in subgroups (e.g., elderly, diabetic, HFpEF).
Ideal Study Design
A prospective cohort of 3,000 pacemaker patients stratified by HF phenotype, measuring BMI and WC at baseline and annually, with mortality as endpoint, using time-dependent ROC analysis to compare predictive accuracy.
Limitation: Still observational — cannot prove WC is causally more important.
Nested Case-Control StudyLevel 2bWhether WC reflects visceral adiposity and inflammation better than BMI in predicting cardiac death.
Whether WC reflects visceral adiposity and inflammation better than BMI in predicting cardiac death.
What This Would Prove
Whether WC reflects visceral adiposity and inflammation better than BMI in predicting cardiac death.
Ideal Study Design
A nested case-control study comparing 150 cardiac deaths to 300 survivors, measuring visceral fat area via CT and serum inflammatory markers, testing whether WC correlates more strongly than BMI with these mediators.
Limitation: Cannot prove WC causes better outcomes — only that it correlates better with biological risk.
Evidence from Studies
Supporting (1)
This study found that for people with pacemakers, how big their waist is predicts how long they’ll live better than their overall weight (BMI). A bigger waist meant higher risk of dying, but BMI didn’t matter much.